The influence of lipoic acid on adriamycin induced nephrotoxicity in rats

Kumaravel Palanichamy Malarkodi1, Andithangal Venkatesan Balachandar, Palaninathan Varalakshmi

  • 1Department of Medical Biochemistry, Dr A.L.M. Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, India.

Insights

Lipoic acid (LA) protects against Adriamycin (ADR)-induced nephrotoxicity by restoring kidney enzyme activities and reducing urinary damage markers. This study highlights lipoic acid

Area of Science:

  • Biochemistry
  • Nephrology
  • Pharmacology

Background:

  • Adriamycin (ADR) is a vital chemotherapeutic agent with known nephrotoxic side effects.
  • Adriamycin-induced kidney damage is characterized by altered enzyme activities and increased urinary biomarkers.
  • Lipoic acid (LA) is an antioxidant with potential protective properties.

Purpose of the Study:

  • To investigate the protective effects of lipoic acid against Adriamycin-induced nephrotoxicity in a rat model.
  • To evaluate the impact of lipoic acid on key renal enzyme activities and urinary damage indicators following Adriamycin administration.

Main Methods:

  • Adult male Wistar rats were divided into four groups: control, Adriamycin (ADR) only, lipoic acid (LA) only, and ADR + LA.
  • Adriamycin was administered intravenously weekly for 12 weeks; lipoic acid was administered intraperitoneally prior to Adriamycin.
  • Activities of glycolytic, gluconeogenic, transmembrane, and TCA cycle enzymes were measured in renal tissue.
  • Urinary excretion of N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transferase was assessed.

Main Results:

  • Adriamycin administration significantly decreased glycolytic, transmembrane, and TCA cycle enzyme activities, indicating renal damage and mitochondrial dysfunction.
  • Increased urinary excretion of N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transferase confirmed Adriamycin-induced nephrotoxicity.
  • Lipoic acid pretreatment effectively counteracted these biochemical disturbances, restoring enzyme activities and normalizing urinary markers.
  • Gluconeogenic enzyme activities further decreased with lipoic acid pretreatment.

Conclusions:

  • Lipoic acid demonstrates significant nephroprotective effects against Adriamycin-induced kidney damage.
  • LA pretreatment helps preserve renal mitochondrial function and membrane integrity by restoring key enzyme activities.
  • These findings support the potential therapeutic role of lipoic acid in mitigating Adriamycin nephrotoxicity.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...